Lupin launches generic Niaspan tablets in US
Pharma major Lupin announced that its US subsidiary Lupin Pharmaceuticals had launched its Niacin Extended-Release tablets USP, 500 mg, 750 mg and 1000 mg strengths, following the final approval from the USFDA on March 20.
Other Corporate Videos
TCS screening candidates for C-suite rejig ahead; COO, CTO posts to be filled soon
Unicorn ed-tech firm Byju's lays off at least 1,000 more employees across various functions
Tata Trusts appoints Siddharth Sharma as CEO, Aparna Uppaluri as COO
Government to release standards for checking fake reviews on e-commerce, other platforms
Reliance retail, Adani group companies among bidders for Future Retail
